Physician profile
Joy A Kroes
NPI 1346568136
$548.83
in general payments reported to CMS, 2019-2025
14 companies · $44.05 in 2025
The $44.05 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $36.82 · 2021: $11.53 · 2022: $71.84 · 2023: $204 · 2024: $78.70 · 2025: $44.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $326.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $131.22 | 2019-2024 | Ozempic, Rybelsus |
| Lilly USA, LLC | $85.63 | 2019-2025 | Mounjaro |
| Pfizer INC. | $51.69 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $37.90 | 2019 | |
| Phadia US INC. | $35.58 | 2020-2023 | Immunocap |
| Exact Sciences Corporation | $34.05 | 2023 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.99 | 2020-2023 | Ofev |
| Abbvie INC. | $26.52 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $25.94 | 2025 | Rexulti |
| Inspire Medical Systems, INC. | $22.87 | 2024 | Inspire |
| Amarin Pharma, INC. | $19.95 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.24 | 2024 | Breztri |
| Glaxosmithkline, LLC. | $15.72 | 2022 | |
| Hologic Sales and Service, LLC | $11.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Kroes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.